WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samuel Bates MartinSVP AND CFO2026-01-024,817$10.38
$50.00kBuy
Ronald PepinSR. VP CBO2025-12-158,333$9.02
$75.14kBuy
Ronald PepinSR. VP CBO2025-12-1511,000$2.78
$30.58kBuy
Freddy A. JimenezSVP GENERAL COUNSEL2025-12-044,166$29.10
$121.21kSell
Richard M. WrightInsider2025-11-1349,298$24.00
$1.18MSell
Richard M. WrightInsider2025-11-136,876$9.02
$62.00kBuy
Richard M. WrightInsider2025-11-1326,672$10.38
$276.86kBuy
Richard M. WrightInsider2025-11-1315,750$22.48
$354.06kBuy

1 of 1

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas S. Paluck9.72%7,632,346$295.45MInsider
Medarex Inc3.77%2,960,848$114.61MInsider
Una S. Ryan1.15%899,213$34.81MInsider
Den Broek Richard Van0.57%448,500$17.36MInsider
Gerald Phd McMahon0.23%180,697$6.99MInsider
Avery W. Catlin0.11%83,586$3.24MInsider
Timothy M. 1. Shannon0.11%83,212$3.22MInsider
Larry Ellberger0.09%73,500$2.85MInsider
Harry Penner Jr.0.05%41,916$1.62MInsider
Karen L. Shoos0.05%41,833$1.62MInsider

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX0.11%16.22%Net Buying
QURE0.09%10.00%Net SellingNet Selling
MBX0.09%99.91%Net BuyingNet Selling
DNLI0.10%57.28%Net SellingNet Selling
ZLAB0.00%1.78%Net BuyingNet Selling
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 0.11% institutional shareholders, 16.22% Celldex Therapeutics insiders, and 83.67% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 9.72% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $297.51M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.